31.03.2008 ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis

26.03.2008 Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL

14.03.2008 Genentech Provides Business Update At Annual Investment Community Meeting

14.03.2008 Amgen to Present at the 28th Annual Cowen Healthcare Conference and the 11th Annual Lehman Brothers Global Healthcare Conference

13.03.2008 Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting

13.03.2008 Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results

12.03.2008 Amgen to Discuss Romiplostim Application at FDA ODAC Meeting

11.03.2008 ACADIA Pharmaceuticals to Present at Lehman Brothers 11th Annual Global Healthcare Conference

07.03.2008 Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13

07.03.2008 Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)

05.03.2008 Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody

05.03.2008 The Colon Cancer Alliance Teams up with Joan Lunden for Amgen Sponsored Workshop Series Designed to Provide Support to Patients and Caregivers

03.03.2008 Genentech Announces March 14 Webcast of Investment Community Meeting